4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

974.29p
   
  • Change Today:
    -10.71p
  • 52 Week High: 1,565.00
  • 52 Week Low: 974.29
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 252
  • Market Cap: £150.98m

Latest Deals

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,117,688 £10,889,474
Amy Walker 44,016 £428,842
Maria Del Pilar de la Huerta 6,667 £64,956
Hansjörg Plaggemars 6,667 £64,956
Timothy Paul McCarthy 2,388 £23,266

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,115,852 £49,843,015
DELPHI Unternehmensberatung AG 5,115,852 £49,843,015
M&G Plc 4,627,741 £45,087,419
Elevage Medical Technologies Holdings 4,627,741 £45,087,419
Deutsche Balaton AG 4,432,637 £43,186,549
4bb AG 3,665,242 £35,709,929
2invest AG 2,229,083 £21,717,637
Sparta AG 1,351,718 £13,169,595
Latonba AG 778,891 £7,588,624
Franciscus De Busschere 537,255 £5,234,399

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 974.29p
Change Today -10.71p
% Change -1.09 %
52 Week High 1,565.00
52 Week Low 974.29
Volume 252
Shares Issued 15.50m
Market Cap £150.98m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.07% below the market average65.07% below the market average65.07% below the market average65.07% below the market average65.07% below the market average
8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average
Price Trend
27.58% below the market average27.58% below the market average27.58% below the market average27.58% below the market average27.58% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Income Not Available
Growth
58.52% above the market average58.52% above the market average58.52% above the market average58.52% above the market average58.52% above the market average
67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average

4basebio Dividends

No dividends found

Trades for 26-Jun-2025

Time Volume / Share Price
11:49 130 @ 992.00p
11:00 120 @ 994.00p
08:32 2 @ 994.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page